Načítá se...
NEXT GENERATION ORAL PrEP: BEYOND TENOFOVIR
PURPOSE: Clinical trials of oral pre-exposure prophylaxis (PrEP) have focused testing on regimens of tenofovir (TDF) with or without emtricitabine (FTC). However, TDF may be associated with toxicities (renal, bone) and FTC may select for drug resistance. In this review, we discuss agents that might...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3732461/ https://ncbi.nlm.nih.gov/pubmed/23032733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/COH.0b013e328358b9ce |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|